| Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. | |
| | |
MedLine Citation:
|
PMID: 9516077 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Insulin-like growth factors (IGFs) are mitogenic and anti-apoptotic peptides that influence the proliferative behavior of many cell types, including normal and transformed breast epithelial cells. IGF-I has properties of both a tissue growth factor and a systemic hormone: there is evidence that IGF bioactivity in tissues is influenced not only by local factors such as tissue expression of IGFs, IGF binding proteins (IGFBPs), and IGFBP proteases, but also by factors that regulate whole-body IGF physiology and circulating IGF-I levels. Experimental evidence that interventions that reduce circulating IGF-I levels reduce proliferation of breast neoplasms has raised interest in the possibility of developing novel endocrine therapies that target the growth hormone/IGF-I axis. Furthermore, influences of the growth hormone/IGF-I axis on normal breast epithelial cells may underlie recent epidemiological observations that suggest that premenopausal women with high circulating IGF-I level are at increased risk for breast cancer. These studies suggest that the growth hormone/IGF-I axis deserves investigation as a possible target for novel breast cancer prevention strategies. |
| | |
Authors:
|
M N Pollak |
Related Documents
:
|
22053997 - Common breast cancer susceptibility alleles are associated with tumor subtypes in brca1... 18826367 - Hypophysectomy for prostate cancer: a revival of old knowledge? 16942817 - Multiple bronchioloalveolar carcinomas in acromegaly: a potential role of insulin-like ... 7612897 - Protein kinases in human breast cancer. 12456287 - Absence of evidence for differences in the dose-response for cancer and non-cancer endp... 9554487 - Multicenter evaluation of the bayer immuno i ca 15-3 assay. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Breast cancer research and treatment Volume: 47 ISSN: 0167-6806 ISO Abbreviation: Breast Cancer Res. Treat. Publication Date: 1998 Feb |
Date Detail:
|
Created Date: 1998-05-04 Completed Date: 1998-05-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8111104 Medline TA: Breast Cancer Res Treat Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 209-17 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Lady Davis Research Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada. MD49@MUSICA.MCGILL.CA |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Breast Neoplasms / pathology*, prevention & control, therapy* Epithelial Cells / pathology Female Humans Insulin-Like Growth Factor I / metabolism, pharmacology, physiology* Mammary Neoplasms, Experimental / pathology, prevention & control, therapy |
| Chemical | |
Reg. No./Substance:
|
67763-96-6/Insulin-Like Growth Factor I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of IGF-I in normal mammary development.
Next Document: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors.